Fortis shares surge over 3% as Q1 revenue jumps 16.5% YoY to Rs 2,166 crore, net profit up 57% YoY
Shares of Fortis Healthcare Ltd rallied over 3% in early trade on Thursday after the company reported a strong set of numbers for the quarter ended June 30, 2025 (Q1 FY26). As of 9:16 AM, the shares 2.59% higher at Rs 880.35.
The hospital chain posted a net profit of ₹260 crore, up 56.6% from ₹166 crore in the same quarter last year. The company's revenue from operations rose 16.5% year-on-year to ₹2,166 crore, compared to ₹1,859 crore in the corresponding period of the previous fiscal. The growth was supported by robust performance across its hospital and diagnostics businesses.
On the operational front, EBITDA (earnings before interest, tax, depreciation and amortisation) stood at ₹490.4 crore, a jump of 43% over ₹343 crore in Q1 FY25. The EBITDA margin improved significantly to 22.6%, from 18.4% in the year-ago period, reflecting enhanced operational efficiencies and better cost management.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
14 hours ago
- Business Upturn
Shilpa Medicare gets CDSCO approval for NorUDCA tablets 500 mg, marks first global clearance for NAFLD treatment
By Aman Shukla Published on August 9, 2025, 10:52 IST Shilpa Medicare Limited has announced that it has received approval from the Central Drugs Standard Control Organization (CDSCO) for its Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg for the treatment of Non-alcoholic Fatty Liver Disease (NAFLD). According to the company, this is the first approval for NorUDCA for NAFLD anywhere in the world. NAFLD is one of the most common liver conditions globally, affecting about 25% of the world's population, which is roughly 1.2 billion people. In India, the estimated patient population is around 188 million. If not addressed in time, NAFLD can progress to non-alcoholic steatohepatitis (NASH) and lead to serious liver complications. NorUDCA is described as having choleretic and anti-inflammatory properties, which can help improve bile flow, reduce inflammation in the liver, and potentially slow the progression of NAFLD and related liver disorders. Data from studies referenced by the company indicate that NorUDCA showed better results compared to placebo, with improvements in liver structure and function and no significant safety issues reported. The approval allows Shilpa Medicare to make NorUDCA available in India for NAFLD treatment. The company has stated that it aims to address an existing treatment gap for patients with this condition. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
14 hours ago
- Business Upturn
Nifty top losers this week (ending August 8): Adani Enterprises, Nestle India, Apollo Hospitals, Infosys and more
By Aman Shukla Published on August 9, 2025, 09:41 IST The Nifty 50 index continued its bearish run by registering its sixth straight weekly loss, a decline streak last witnessed during the turbulent early days of the COVID-19 pandemic in February-March 2020, when the index corrected for seven consecutive weeks. This week saw sharp declines across key market segments. The Nifty Bank index took a significant hit, plunging over 350 points during intraday trading and ending nearly 600 points lower by week's close. The Nifty Midcap index also suffered heavy losses, dropping 660 points intraday and closing 936.1 points down for the week. Several heavyweight stocks took a significant hit this week. Based on data from Trendlyne, here are the top 10 losers from the Nifty 50: Top Nifty Losers for the Week Adani Enterprises closed at 2178.1, down 7.4% for the week. Nestle India ended at 1096.5, down 3.7% for the week. Apollo Hospitals Enterprises closed at 7084.5, down 3.6% for the week. Infosys shares ended at 1423.1, down 3.2% for the week. Sun Pharmaceutical Industries finished at 1586.9, down 2.6% for the week. Jio Financial Services closed at 321.2, down 2.5% for the week. ICICI Bank ended at 1435.9, down 2.4% for the week. Tata Motors closed at 633.7, down 2.3% for the week. Power Grid Corporation ended at 284.9, down 2.2% for the week. Hindustan Unilever closed at 2498.6, down 2.2% for the week. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Adani enterprisesApollo HospitalsInfosysNestle IndiaNifty Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
14 hours ago
- Business Upturn
ICICI Bank account holders will now have to keep Rs 50,000 as minimum balance vs Rs 10,000 earlier
By Aditya Bhagchandani Published on August 9, 2025, 09:33 IST ICICI Bank has announced a sharp increase in the minimum average monthly balance (MAB) requirement for its savings account holders in metro and urban locations. Effective October 1, 2025, customers in these areas will need to maintain a minimum balance of Rs 50,000, compared to the current requirement of Rs 10,000. The move marks a fivefold jump in the balance requirement, aimed at revising the bank's account maintenance norms in line with market conditions. According to the bank's updated schedule of charges, non-maintenance of the minimum balance will attract penalties as per the revised slab rates, which will also come into effect from October 1. The revision applies only to customers with savings accounts in metro and urban branches, while semi-urban and rural account holders will continue with the existing minimum balance requirements. ICICI Bank has advised customers to review their account balances ahead of the change to avoid non-maintenance charges. The update is part of a broader industry trend where banks are reviewing account-related fees and conditions to align with evolving cost structures and deposit mobilization strategies. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
